Status:

UNKNOWN

PET/CT to Identify "Vulnerable" Arterial Plaque

Lead Sponsor:

Rambam Health Care Campus

Conditions:

Cancer

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the...

Eligibility Criteria

Inclusion

  • Patients referred for clinical FDG-PET/CT studies
  • Patients 50 yr or older
  • Patients signed informed consent

Exclusion

  • Patients unable or unwilling to tolerate the scan until its completion

Key Trial Info

Start Date :

April 1 2004

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT00416065

Start Date

April 1 2004

Last Update

December 27 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rambam Medical Center

Haifa, Israel

PET/CT to Identify "Vulnerable" Arterial Plaque | DecenTrialz